United States Food and Drug Administration

You have accessRestricted Access
A Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies
Joseph V. Bonventre, Frank P. Hurst, Melissa West, Iwen Wu, Prabir Roy-Chaudhury and Murray Sheldon

CJASN October 2019, 14 (10) 1539-1547; DOI: https://doi.org/10.2215/CJN.02570319

Add to Selected Citations
Open Access
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease
Nishank Jain and Robert F. Reilly

CJASN February 2019, 14 (2) 278-287; DOI: https://doi.org/10.2215/CJN.02170218

Add to Selected Citations
You have accessRestricted Access
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Fouad T. Chebib and Vicente E. Torres

CJASN November 2018, 13 (11) 1765-1776; DOI: https://doi.org/10.2215/CJN.03960318

Add to Selected Citations
You have accessRestricted Access
Regulatory Considerations for Hemodiafiltration in the United States
Richard A. Ward, Jörg Vienken, Douglas M. Silverstein, Stephen Ash and Bernard Canaud; on behalf of the Kidney Health Initiative HDF Workgroup

CJASN September 2018, 13 (9) 1444-1449; DOI: https://doi.org/10.2215/CJN.12641117

Add to Selected Citations
You have accessRestricted Access
Recommended Clinical Trial End Points for Dialysis Catheters
Michael Allon, Deborah J. Brouwer-Maier, Kenneth Abreo, Kevin M. Baskin, Kay Bregel, Deepa H. Chand, Andrea M. Easom, Leonard Mermel, Michele H. Mokrzycki, Priti R. Patel, Prabir Roy-Chaudhury, Surendra Shenoy, Rudolph P. Valentini and Haimanot Wasse

CJASN March 2018, 13 (3) 495-500; DOI: https://doi.org/10.2215/CJN.12011116

Add to Selected Citations

Main menu

User menu

Search

United States Food and Drug Administration

About

Author Information

More information